[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
June 13, 2007

Drug Reimbursements

JAMA. 2007;297(22):2465. doi:10.1001/jama.297.22.2465-c

More than 400 000 low-income beneficiaries may have missed out on millions of dollars in federal subsidies to help pay for prescription drug purchases under Medicare Part D, said a report released by the Government Accountability Office on May 8.

The report, compiled at the request of Sen Max Baucus (D, Mont), chairman of the Senate Finance Committee, said the Centers for Medicare & Medicaid Services (CMS), failed to notify “dual-eligible” beneficiaries (those qualifying for Medicare and Medicaid) that they were eligible for reimbursement on previous prescription drug purchases when they began the enrollment process for Medicare Part D but had not yet been formally approved—a process that takes a minimum of 5 weeks.

First Page Preview View Large
First page PDF preview
First page PDF preview
×